Interní Med. 2009; 11(9): 405-409

Toxic shock syndrome

MUDr. Jana Táborská Ph.D
Infekční klinika FN a LF UK, Plzeň

The overwiev of current knowledges of toxic shock syndrome. Toxic shock syndrome is a multiorgan disease caused by toxins that is

characterized by rapid onset of shock and significant lethality. Two microbes are included in the etiology of the disease. Staphylococcus

aureus producing TSST-1 and enterotoxins cause staphylococcal toxic shock syndrome. Strains of Streptococcus pyogenes that involve

some M proteins and produce pyrogen exotoxins cause streptococcal toxic shock syndrome. The pathogenesis of both types of infection,

clinical picture, diagnosis and differential diagnosis, treatment and possible prophylactic measures are described.

Keywords: toxic shock syndrome, Staphylococcus aureus, Streptococcus pyogenes, toxins.

Published: October 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Táborská J. Toxic shock syndrome. Interní Med. 2009;11(9):405-409.
Download citation

References

  1. Beneš J, Petráš P, Kabelková M. Syndrom toxického šoku: souborná práce a kasuistika. Klin Mikrobiol Inf Lék 1998; 4: 120-125.
  2. Herzer CHM. Toxic shock syndrome: Broadening and differential diagnosis. J Am Board Fam Pract 2001; 14 (2): 131-136. Go to PubMed...
  3. Issa N C, Thompson R L. Staphylococcal toxic shock syndrome. Suspicion end prevention are keys to kontrol.
  4. Petráš P. Dva případy stafylokokového syndromu toxického šoku II. Původní diagnóza apendicitida. Zprávy CEM (SZÚ Praha) 2003; 12 (2): 76.
  5. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978; 2: 1116. Go to original source... Go to PubMed...
  6. Táborská J, Petráš P. Další případ syndromu toxického šoku III. Původní diagnóza salmonelóza. Zprávy CEM (SZÚ Praha) 2004; 13 (3): 119-120.
  7. Kosina P, Plíšek S, Dostál V, et al. Invazivní streptokokové infekce. Klin Mikrobiol Inf Lék 2007; 13 (6): 220-224.
  8. Andrews MM, Parent Barry M, Parsonnet J. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis and treatment. Clin Infect Dis 2001; 32: 1470. Go to original source... Go to PubMed...
  9. Golden S. Group A streptococcus and streptococcal toxic shock syndrome: A postpartum case report. J Midwifery Womens Health 2003; 48 (5): 357-359. Go to original source... Go to PubMed...
  10. Petráš P, Džupová O. Stafylokokový syndrom toxického šoku. Včas vyslovené podezření a prevence jsou předpokladem zvládnutí akutního syndromu. Medicína po promoci 2002; 3 (3): 29-37.
  11. Petráš P. Syndrom toxického šoku v České republice - 41 zaznamenaných případů z let 1983-1997. Klin Mikrobiol Inf Lék 1998; 4: 126-130.
  12. Petráš P, Džupová O, Beneš J. Dva případy stafylokokového syndromu toxického šoku I. Původní diagnóza meningitida. Zprávy CEM (SZÚ Praha) 2003; 12 (1): 24-25. Go to original source...
  13. Straková L, pracovní skupina Strep-EURO, Motlová J, Urbánková P, Křížová P. Surveillance závažných onemocnění působených streptokoky skupiny A v České republice v roce 2003 - projekt Strep-EURO. Epidemiol. Mikrobiol. Imunol. 2004; 53 (3): 106-111. Go to PubMed...
  14. Špidlenová A, Táborská J, Koubová A, et al. Syndrom toxického šoku u hospitalizovaných nemocných (1985-1997). Prak Lék 1998; 78 (4): 166-169.
  15. Norrby-Teglund A, Muller MP, Mcgeer A, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2005; 37 (3): 166-172. Go to original source...
  16. Stevens DL. Streptococcal toxic shock syndrome. Clin Microbiol Infect. 2002; 8 (3): 133-136. Go to original source... Go to PubMed...
  17. Beneš J, Kabelková M, Kořínková M, Petráš P. Syndrom toxického šoku jako následek vulvovaginitidy. Zprávy CEM (SZÚ Praha) 2004; 13 (12): 509-510.
  18. O´Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45 (7): 853-862. Go to original source... Go to PubMed...
  19. Darenberg J, Soderquist B, Normark BH, Norby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 2004; 38: 836. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.